Oura and Counsel Partner with CMS ACCESS Model to Bring AI-Native Chronic Care to Medicare Beneficiaries

The intersection of wearable technology and federal healthcare policy reached a significant milestone today as smart-ring manufacturer Oura announced an expanded partnership with Counsel, an artificial intelligence-native primary care provider. The collaboration is designed to leverage the Centers for Medicare & Medicaid Services Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. This federal initiative provides a structured framework for Oura and Counsel to study the integration of continuous biometric data with physician-led care at a national scale. The primary objective is to evaluate how modern digital health tools can effectively support Medicare beneficiaries who are actively managing chronic medical conditions.

Beginning in early 2027, Counsel will roll out its AI-native chronic care delivery model targeting conditions such as hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, this specialized care will be provided at no out-of-pocket cost to eligible Medicare beneficiaries residing across nearly all United States jurisdictions. By coupling federal health innovation pathways with private-sector technological infrastructure, the initiative aims to bridge the longstanding gap between passive health monitoring and active, clinical intervention for an older demographic that often requires coordinated long-term management.

Background and Chronological Evolution of the Partnership

The roots of this new federal healthcare initiative trace back to a foundational collaboration established in May, when Oura and Counsel first joined forces. That initial commercial partnership was created to address a common friction point in consumer digital health: the transition from passive health tracking to actionable clinical care. Historically, wearable devices generated vast amounts of physiological data—ranging from resting heart rate and heart rate variability to sleep stages and temperature trends—leaving users to interpret these metrics independently. The Oura-Counsel integration allowed members to seamlessly translate continuous health insights directly into clinician-led action.

Under the original framework, Oura members received ongoing visibility into subtle shifts in their physiological baseline. When health signals indicated potential areas of concern, Counsel’s medical artificial intelligence and network of board-certified physicians stepped in to help interpret those data points, offering structured guidance and telehealth consultations.

Data gathered during the initial months of this integration demonstrated strong consumer reception and clinical viability. Oura members who utilized the Counsel integration reported high levels of satisfaction, rating their physician-led care experiences at an impressive 4.6 out of 5. Users frequently highlighted the convenience of the digital interface and the clarity provided by clinicians in helping them make sense of complex biometric trends. Encouraged by these positive pilot outcomes, both organizations sought a larger stage to test and validate their methodology. The CMS ACCESS Model presented an ideal vehicle for this expansion, enabling the partners to scale their framework specifically for Medicare beneficiaries while simultaneously contributing valuable data to federal healthcare researchers.

Demographic Realities and the Burden of Chronic Disease

The decision to focus the ACCESS program on cardiovascular and metabolic conditions is heavily supported by demographic and epidemiological data within Oura’s existing user base. Contrary to the assumption that wearable technology is exclusively adopted by younger demographics, adults aged 65 and older represent one of Oura’s most highly engaged cohorts. These older users demonstrate exceptional daily app engagement, regularly reviewing their biometric metrics and integrating the device into their morning and evening routines.

Furthermore, internal usage data reveals that approximately 20 percent of Oura members within this senior age bracket present with a Body Mass Index of 30 or higher, placing them in the clinical category for obesity. Obesity is a primary catalyst for a cascade of related chronic illnesses, including hypertension, hyperlipidemia, and prediabetes, which collectively drive a disproportionate share of healthcare expenditures in the United States.

Managing these cardio-kidney-metabolic conditions requires consistent, longitudinal monitoring rather than episodic, reactive check-ups that occur only a few times a year in a traditional physician’s office. By capturing continuous biometric data—such as nocturnal heart rate drops, activity levels, and stress indicators—the Oura Ring provides a high-resolution window into a patient’s daily physiological status. When this continuous data stream is paired with Counsel’s on-demand, personalized artificial intelligence and physician oversight, care teams gain unprecedented visibility into how lifestyle modifications, medications, and disease management strategies are performing in real-world environments.

Operational Mechanics of the ACCESS Program Integration

The operational structure of the ACCESS rollout is designed to minimize administrative friction for patients while maintaining rigorous clinical standards. Oura will serve as an informational and technological bridge, utilizing the Oura App to surface educational materials and program details to eligible members who meet the age and health criteria established by the CMS model.

Once an interested member expresses interest through the application interface, Counsel takes over the administrative and clinical workflows. Counsel’s team independently verifies clinical eligibility according to CMS guidelines, manages formal enrollment, and oversees the delivery of care. This division of labor ensures that while Oura provides the hardware and user-interface touchpoints, licensed medical professionals retain full autonomy over patient diagnosis, treatment planning, and clinical decision-making.

Starting in early 2027, eligible participants will receive access to Counsel’s specialized care protocols at zero out-of-pocket cost. This financial accessibility is a cornerstone of the CMS ACCESS Model, which seeks to eliminate cost-sharing barriers that traditionally deter lower-income or fixed-income Medicare beneficiaries from engaging with proactive chronic disease management programs.

Official Perspectives and Leadership Commentary

Executives from both organizations have emphasized the broader implications of combining federal innovation programs with consumer-grade health technology. Industry stakeholders view this initiative as a testing ground for the future of value-based care, where continuous data feeds could eventually become standard components of clinical workflows.

Dr. Ricky Bloomfield, Chief Medical Officer at Oura, articulated the strategic vision behind the partnership during the official announcement. "Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," Dr. Bloomfield stated. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

While Counsel will manage the direct patient care delivery, the broader implications of the initiative extend to how federal agencies evaluate digital health interventions. By participating in the ACCESS Model, Oura and Counsel are positioning themselves at the forefront of policy discussions regarding remote patient monitoring, algorithmic triage, and telehealth reimbursement structures.

Broader Industry Implications and Future Outlook

The inclusion of consumer wearable technology into a CMS-backed innovation model signals a maturing relationship between the federal healthcare apparatus and the consumer tech sector. For years, skeptics argued that consumer health devices produced unstructured, non-medical-grade data that could overwhelm clinical systems rather than aid them. However, initiatives like the ACCESS Model suggest that when paired with AI-native triage systems—such as those deployed by Counsel—continuous biometric data can be effectively filtered, interpreted, and acted upon by licensed physicians.

This model addresses several systemic challenges within the U.S. healthcare system:

• Physician burnout is mitigated by AI tools that handle routine data organization and preliminary patient triage.
• Patient empowerment is enhanced through daily feedback loops that encourage adherence to treatment plans.
• Health equity is addressed by removing financial barriers for Medicare beneficiaries dealing with complex, systemic conditions.

As the launch date in early 2027 approaches, Oura plans to release detailed enrollment instructions and eligibility criteria directly through the Oura App. For the millions of older adults navigating chronic illness, the convergence of continuous biometric tracking and accessible, physician-led care may well establish a new benchmark for proactive, technology-enabled aging in place.